GEORGE BRIGHT: Open Payments
NPI 1235181702 · MIDLOTHIAN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$15,624 in 111 payments from 14 companies in 2025. Trend: 2023 $40,555 · 2024 $25,869 · 2025 $15,624
Speaker / faculty: $11,300Food & beverage: $2,024Consulting: $1,500Honoraria: $800
| Company | Payments | Amount |
|---|---|---|
| Tris Pharma Inc | 25 | $9,729 |
| AYTU BioPharma, Inc. | 2 | $2,250 |
| Neos Therapeutics, LP | 15 | $1,463 |
| Eton Pharmaceuticals, Inc. | 1 | $1,000 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 31 | $397 |
| Otsuka America Pharmaceutical, Inc. | 12 | $276 |
| Corium, LLC | 7 | $185 |
| Collegium Pharmaceutical, Inc. | 10 | $153 |
| Lundbeck LLC | 3 | $65 |
| Axsome Therapeutics, Inc. | 1 | $26 |
Products named: Dyanavel XR, Adzenys XR-ODT, ALKINDI, CAPLYTA, REXULTI, EXXUA, Azstarys, Jornay PM.
Industry payments across VA — which companies pay providers there.
